References
- Zacharski LR. Rationale for treatment of cancer with calcium antagonists. A review. J Med 1988; 19: 145–177.
- Tsuruo T, lida H, Makishina F, et al. Inhibition of spontaneous and experimental tumour metastasis by the calcium antagonists verapamil. Cancer Chemother Pharmacol 1985; 14: 30–33.
- Tsuruo T. Treatment of tumours with calcium antagonists. ISI Atlas Sci Pharmacol 1987; 1: 325–327.
- Bando H, Yamashita T, Tsuruba E. Effects of antiplatelet agents on pulmonary metastases. Gann 1984; 75: 284–291.
- Gastpar H, Ambrus JL, Ambrus CM. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations. J Med 1981; 1: 1533.
- Honn HV, Onoda JM, Diglio CA, Sloane BF. Calcium channel blockers: potential antimetastatic agents. Proc Soc Exp Biol Med 1983; 174: 16–19.
- Yoneda T, Kitamura M, Ogawa T, Aya S, Sakuda M. Control of VX2 carcinoma cell growth in culture by calcium, calmodulin and prostaglandins. Cancer Res 1985; 45: 398.
- Onoda JM, Mentor DG, Sloane BF, et al. Calcium channel blockers: inhibitors of tumour cell-platelet endothelial cell interactions. In: Honn HV, Sloane BF, eds. Hemostatic mechanisms and metastasis. Boston: Martinus Nijhoff 1984; 244–258.
- Fidler IJ. Tumour heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 1978; 38: 2651–2660.
- Nekagawa Y, Gudenzi M, Mustafa SJ. Calcium entry blocking activity of adenosine compounds in guinea-pig atria. Eur J Pharmacol 1986; 122: 51–58.
- Pippia P, Cogoli A, Gaias M, Piras G, Ivaldi G. Determination of adhesive rate constant in normal and neoplastic homogeneic cells. Experientia 1981; 37: 698–700.
- Pippia P, Cogoli A, Tilloca G, Ivaldi G. Recognition sites involved in the adhesive processes of neoplastic and normal homogeneic cells. Experientia 1983; 39: 1396–1397.
- Coman DR. Adhesiveness and stickiness: two independent properties of the cell surface. Cancer Res 1961; 2: 1436–1438.